Autophagy and its Regulation in Diabetic Embryopathy
Autophagy and its Regulation in Diabetic Embryopathy
批准号:
10653278
负责人:
Peixin Yang
金额:
$40.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-05-07 至 2025-02-28
关键词:
2019-nCoV4 hydroxynonenalACE2AddressApoptosisAsthmaAutolysisAutophagocytosisBiologicalBrain InjuriesCOVID-19COVID-19 diagnosisCOVID-19 patientCOVID-19 riskCOVID-19 treatmentCell DeathCell Fate ControlCellsCesarean sectionChronicClinicalDetectionDevelopmentDiseaseEtiologyEventFetal Growth RetardationFormalinFunctional disorderGene ExpressionGlycoproteinsHeart InjuriesHormonesHumanImmunofluorescence ImmunologicIn Situ HybridizationIn VitroIndividualInfectionInflammationInjuryIronKnowledgeLinkLipid PeroxidationMalignant NeoplasmsMalondialdehydeMissionMolecularMononuclearNecrosisNeonatalNucleocapsidOutcomeOvarianOxidation-ReductionOxidative StressParaffin EmbeddingPathogenesisPathologyPathway interactionsPhospholipidsPhysiologicalPhysiologyPlacentaPlayPolyunsaturated Fatty AcidsPre-EclampsiaPregnancyPregnancy ComplicationsPregnancy RatePregnant WomenPreventiveProcessPublic HealthRNARNA VirusesRegulationReportingResearchRisk FactorsRoleSARS-CoV-2 infectionSafetySignal PathwaySignal TransductionStainsSyncytiotrophoblastTherapeutic InterventionTissuesTrophoblastic CellUnited States National Institutes of HealthUterusViral GenomeVirionVirus Diseasesadverse pregnancy outcomecell injurycoronavirus diseasecytokinecytotrophoblastdiabetic embryopathyexperiencefetalhistiocytehuman diseasein vitro Modeliron metabolismmammaryneonatenew therapeutic targetnovelnovel therapeutic interventionobstetric outcomesobstetrical complicationparaformperoxidationprematurereceptorrepairedresponsestillbirththerapeutically effectivetrophoblast
中文摘要
SARS-CoV-2感染诱导胎盘铁下垂激活
英文摘要
SARS-CoV-2 infection induces activation of ferroptosis in the placenta
Summary
Pregnancy is a risk factor for SARS-CoV-2 infection and worse COVID-19 outcomes. Therefore, there is an
urgent need for research into underlying mechanisms leading to the pathogenesis of adverse pregnancy
outcomes and the development of optimal COVID-19 treatment during pregnancy. Most adverse pregnancy
outcomes are of placental origin because the human placenta can synthesize many hormones and cytokines to
influence ovarian, uterine, mammary, and fetal physiology. Recent advances in understanding cell death
mechanisms in cell death mechanisms have led to significant recognition of the role of ferroptosis in regulating
cell fate. As a form of nonapoptotic programmed cell death, ferroptosis is characterized by redox-active iron-
dependent hydroxy-peroxidation of polyunsaturated fatty acid-containing phospholipids and compromised lipid
peroxidation repair capacity. Because dysregulation of iron metabolism plays has been shown to play an
important role in the etiology of COVID-19, the central hypothesis of this study is that SARS-CoV-2 infection
leads to activation of the ferroptosis process in the placenta, thereby serving as a pivotal contributor to
dysregulation of placental function and subsequently pathogenesis of adverse pregnancy outcomes.
We plan to pursue two Aims. Aim 1. To determine gene expression levels of hallmarks of ferroptosis in
SARS-CoV-2-infected human primary placental tissues and trophoblastic cells. A number of studies have
shown increased COVID-19 risk among pregnant women experiencing obstetrical complications. While multiple
underlying signaling pathways may associate these two events, we hypothesize that ferroptosis is primarily
responsible. Aim 2. To recapitulate SARS-CoV-2 infection-induced activation of the ferroptosis process
in the placenta in vitro. We will use human primary placental cytotrophoblast as an in vitro model to accomplish
this Aim. This research is significant because it addresses a fundamental question regarding mechanisms
underlying correlation of COVID-19 and pathogenesis of adverse clinical outcomes. Furthermore, this study
explores a novel concept: ferroptosis signaling can serve as such a mechanism, thus facilitating development of
new and effective therapeutic approaches for treatment of these complications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular Stress-Induced Gene Dysregulation in Heart Defects Formation of Diabetic Pregnancy
-
批准号:10186804
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2020
-
负责人:Peixin Yang
-
依托单位:
Cellular Stress-Induced Gene Dysregulation in Heart Defects Formation of Diabetic Pregnancy
-
批准号:10438808
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2020
-
负责人:Peixin Yang
-
依托单位:
Cellular Stress-Induced Gene Dysregulation in Heart Defects Formation of Diabetic Pregnancy
-
批准号:10657369
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2020
-
负责人:Peixin Yang
-
依托单位:
Maternal Diabetes-Suppressed Vascular Signaling Induces Vasculopathy and Neural Tube Defects
-
批准号:9080869
-
项目类别:
-
资助金额:$51.97万
-
财政年份:2016
-
负责人:Peixin Yang
-
依托单位:
Maternal Diabetes-Suppressed Vascular Signaling Induces Vasculopathy and Neural Tube Defects
-
批准号:9324027
-
项目类别:
-
资助金额:$52.12万
-
财政年份:2016
-
负责人:Peixin Yang
-
依托单位:
Autophagy and its Regulation in Diabetic Embryopathy
-
批准号:8674834
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2014
-
负责人:Peixin Yang
-
依托单位:
Autophagy and its Regulation in Diabetic Embryopathy
-
批准号:10360659
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2014
-
负责人:Peixin Yang
-
依托单位:
Autophagy and its Regulation in Diabetic Embryopathy
-
批准号:10160931
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2014
-
负责人:Peixin Yang
-
依托单位:
Autophagy and its Regulation in Diabetic Embryopathy
-
批准号:9215665
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2014
-
负责人:Peixin Yang
-
依托单位:
Autophagy and its Regulation in Diabetic Embryopathy
-
批准号:8823774
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2014
-
负责人:Peixin Yang
-
依托单位:
Autophagy and its Regulation in Diabetic Embryopathy
-
批准号:10577755
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2014
-
负责人:Peixin Yang
-
依托单位:
Metabolic Cellular Stress and its Regulatory Mechanism in Diabetic Embryopathy
-
批准号:8536445
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2012
-
负责人:Peixin Yang
-
依托单位:
Apoptotic Mechanism of Maternal Diabetes-Induced Neural Tube Defects
-
批准号:7792024
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2010
-
负责人:Peixin Yang
-
依托单位:
Apoptotic Mechanism of Maternal Diabetes-Induced Neural Tube Defects
-
批准号:8032526
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2010
-
负责人:Peixin Yang
-
依托单位:
Apoptotic Mechanism of Maternal Diabetes-Induced Neural Tube Defects
-
批准号:8609566
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2010
-
负责人:Peixin Yang
-
依托单位:
Apoptotic Mechanism of Maternal Diabetes-Induced Neural Tube Defects
-
批准号:8433978
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2010
-
负责人:Peixin Yang
-
依托单位:
Apoptotic Mechanism of Maternal Diabetes-Induced Neural Tube Defects
-
批准号:8225380
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2010
-
负责人:Peixin Yang
-
依托单位:
海外基金